Why Clarivate Plc’s (CLVT) Stock Is Down 5.07%
As of Tuesday, September 08, Clarivate Plc’s CLVT share price has dipped by 5.07%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Commentary & Analysis
Why Clarivate Plc’s (CLVT) Stock Is Up 7.52%
As of Thursday, September 03, Clarivate Plc’s CLVT share price has surged by 7.52%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Clarivate Plc’s (CLVT) Stock Is Up 5.85%
As of Tuesday, September 01, Clarivate Plc’s CLVT share price has surged by 5.85%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Clarivate Plc’s (CLVT) Stock Is Up 7.04%
As of Thursday, August 27, Clarivate Plc’s CLVT share price has surged by 7.04%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Clarivate Plc’s (CLVT) Stock Is Up 5.56%
As of Wednesday, August 19, Clarivate Plc’s CLVT share price has surged by 5.56%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | CLVT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,029.9 | $1,091.3 | 46% |
|
| Shares Out (Mil) | 639.4 | 40.9 | 90% |
|
| Institutional Ownership | 97.0% | 86.5% | 72% |
|
| Float (Mil) | 468.4 | 34.6 | 84% |
|
| Beta | 1.39 | 0.80 | 79% |
|
| Avg Daily Volume (000s) | 3,615 | 436 | 89% |
|
| Price Change (52-week) |
(56.8%) | 70.2% | 16% |
|
| Growth | CLVT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.4% | 7.4% | 72% |
|
| Net Income (5yr) | 10.5% | 8.0% | 56% |
|
| EPS (5yr) | 18.2% | 11.8% | 65 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (35.8%) | (15.1%) | 14% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 3 | 3 | |
| Current EPS | $0.159 | $0.719 | $0.776 | |
| Month Ago EPS | $0.159 | $0.714 | $0.724 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $0.169 | $0.731 | $0.739 | |
| Year/Year Chg | (137.9%) | (339.7%) | (401.7%) | |
| Financials | CLVT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,413 | $1,504 | 63% |
|
| Net Income (TTM) (Mil) | ($334) | $36 | 4% |
|
| EPS (TTM) | ($0.513) | $0.900 | 27% |
|
| Operating Cash Flow (TTM) (Mil) | $574 | $173 | 73% |
|
| Net Cash Flow (TTM) (Mil) | ($145) | $0 | 12% |
|
| Long-Term Debt (Q1) (Mil) | $4,239 | $236 | 84% |
|
| Enterprise Value (Q1) (Mil) | $5,292 | $1,774 | 64% |
|
| Valuation | CLVT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.23 | 2.53 | 4% |
|
| P/E | na | 23.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | CLVT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 66.8% | 36.0% | 78% |
|
| Net Margin | (13.8%) | 3.5% | 19% |
|
| ROA | (3.0%) | 3.2% | 33% |
|
| ROE | (7.0%) | 8.4% | 29% |
|
| Liabilities to Assets | 56.7% | 59.0% | 50% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 10/9/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Price-to-Free-Cash-Flow Screen
Factors: Value
An exploration of the basics of cash flow analysis and the implementation of a price-to-free-cash-flow screen.
| Performance Since Inception: | 16.3% |
| +/- S&P 500: | +8.8 |
